Author
Listed:
- Ulrike Steffen
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Carolien A. Koeleman
(Leiden University Medical Center, Center for Proteomics and Metabolomics, Glycomics and Clinical Proteomics Group)
- Maria V. Sokolova
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Holger Bang
(Orgentec Diagnostika)
- Arnd Kleyer
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Jürgen Rech
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Harald Unterweger
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Martin Schicht
(Friedrich Alexander University Erlangen-Nürnberg)
- Fabian Garreis
(Friedrich Alexander University Erlangen-Nürnberg)
- Jonas Hahn
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Fabian T. Andes
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Fabian Hartmann
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Madelaine Hahn
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Aparna Mahajan
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Friedrich Paulsen
(Friedrich Alexander University Erlangen-Nürnberg)
- Markus Hoffmann
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Günter Lochnit
(Justus-Liebig-University Giessen)
- Luis E. Muñoz
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Manfred Wuhrer
(Leiden University Medical Center, Center for Proteomics and Metabolomics, Glycomics and Clinical Proteomics Group)
- David Falck
(Leiden University Medical Center, Center for Proteomics and Metabolomics, Glycomics and Clinical Proteomics Group)
- Martin Herrmann
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
- Georg Schett
(Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen)
Abstract
Monomeric serum immunoglobulin A (IgA) can contribute to the development of various autoimmune diseases, but the regulation of serum IgA effector functions is not well defined. Here, we show that the two IgA subclasses (IgA1 and IgA2) differ in their effect on immune cells due to distinct binding and signaling properties. Whereas IgA2 acts pro-inflammatory on neutrophils and macrophages, IgA1 does not have pronounced effects. Moreover, IgA1 and IgA2 have different glycosylation profiles, with IgA1 possessing more sialic acid than IgA2. Removal of sialic acid increases the pro-inflammatory capacity of IgA1, making it comparable to IgA2. Of note, disease-specific autoantibodies in patients with rheumatoid arthritis display a shift toward the pro-inflammatory IgA2 subclass, which is associated with higher disease activity. Taken together, these data demonstrate that IgA effector functions depend on subclass and glycosylation, and that disturbances in subclass balance are associated with autoimmune disease.
Suggested Citation
Ulrike Steffen & Carolien A. Koeleman & Maria V. Sokolova & Holger Bang & Arnd Kleyer & Jürgen Rech & Harald Unterweger & Martin Schicht & Fabian Garreis & Jonas Hahn & Fabian T. Andes & Fabian Hartma, 2020.
"IgA subclasses have different effector functions associated with distinct glycosylation profiles,"
Nature Communications, Nature, vol. 11(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-019-13992-8
DOI: 10.1038/s41467-019-13992-8
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Anna Halama & Shaza Zaghlool & Gaurav Thareja & Sara Kader & Wadha Al Muftah & Marjonneke Mook-Kanamori & Hina Sarwath & Yasmin Ali Mohamoud & Nisha Stephan & Sabine Ameling & Maja Pucic Baković & Jan, 2024.
"A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes,"
Nature Communications, Nature, vol. 15(1), pages 1-23, December.
- Janice Z. Jia & Carolyn A. Cohen & Haogao Gu & Milla R. McLean & Raghavan Varadarajan & Nisha Bhandari & Malik Peiris & Gabriel M. Leung & Leo L. M. Poon & Tim Tsang & Amy W. Chung & Benjamin J. Cowli, 2024.
"Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children,"
Nature Communications, Nature, vol. 15(1), pages 1-15, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-019-13992-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.